Kinox (Ciprofloxacin)

Ciprofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By inhibiting these targets, the drug prevents bacterial cells from multiplying, leading to their death. This mechanism provides broad‑spectrum activity against many Gram‑negative and some Gram‑positive bacteria.

The dosage of Kinox is individualized by the prescriber based on the type and severity of infection, patient age, weight, renal function, and other clinical factors. Only a qualified healthcare provider can determine the appropriate dose and treatment length for each patient.

Ciprofloxacin is generally avoided during pregnancy and lactation unless the potential benefit outweighs the risk. Limited data exist, and the drug may cross the placenta or appear in breast milk. Physicians should evaluate the necessity and consider alternative agents when treating pregnant or nursing patients.

To request Kinox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kinox (ciprofloxacin) shares the class‑wide mechanism of DNA gyrase inhibition with other fluoroquinolones, but it has a distinct spectrum of activity, pharmacokinetic profile and safety considerations. Compared with agents like levofloxacin or moxifloxacin, ciprofloxacin often offers stronger activity against Gram‑negative organisms but may have a higher risk of tendon‑related adverse events.

Kinox tablets should be stored at room temperature below 25 °C, in the original blister or container, protected from moisture and direct sunlight. Keeping the product in a dry environment helps maintain its potency throughout the shelf life.

Kinox is taken orally, usually with a full glass of water. The tablet should be swallowed whole and not chewed or crushed unless directed by a healthcare professional. Food may be taken with the dose, but antacids containing aluminium or magnesium should be spaced at least two hours apart.

Serious adverse reactions to ciprofloxacin include tendon rupture or tendinitis, especially in the Achilles tendon, peripheral neuropathy, severe allergic reactions (anaphylaxis), QT interval prolongation leading to arrhythmias, and Clostridioides difficile‑associated colitis. Patients should seek immediate medical attention if they experience sudden joint pain, numbness, or severe gastrointestinal symptoms.

Kinox is contraindicated in individuals with a known hypersensitivity to ciprofloxacin or other fluoroquinolones. It should also be avoided in patients with a history of tendon disorders related to fluoroquinolone use, those taking concomitant medications that significantly prolong the QT interval, and in situations where safer alternative antibiotics are available.